Hints and tips:
...Oxford BioMedica is a world leader in producing “lentiviral vectors” — viruses used in gene therapy to carry disease-correcting DNA into patients’ cells....
...Oxford BioMedica, a spinout from Oxford university, jumped 25 per cent after it announced a collaboration with Novartis....
...I know this purchase has made my Sipp even more overweight in the pharmaceuticals sector, since it also has stakes in BTG, Epistem, Immupharma, Oxford Biomedica and Novartis....
...Oxford Biomedica dropped to a record low, down 30.5 per cent to 3.3p after test results for ProSavin, its treatment for Parkinson’s disease, disappointed investors....
...BSkyB rose 2 per cent to 743p on assumptions that the very public demotion of Vince Cable after his media gaff made a bid by parent company News Corp more likely to gain regulatory approval....
...Oxford BioMedica, a well-known UK biotech company which spun out of Oxford University, has been based there since 1997....
...Oxford Biomedica, the biotechnology group, climbed 12.7 per cent to 37¾p as it announced its seventh licence agreement for its Lentivector gene delivery technology with an unnamed Fortune 500 global biotech...
...One rumour suggested a bid for the whole company was in the offing, even though US group Hilton Hotels Corp’s bid for the International unit is believed to be close to agreement....
...Oxford Biomedica slumped 20.4 per cent to 19.5p after the gene therapy company said offer talks with a mystery suitor had ended....
...I used some of the proceeds from these sales to invest in oil minnows Westmount Energy and Falkland Oil Gas and in pharmaceuticals firms Provalis and Oxford Biomedica....
...After a rise of 11.6 per cent on Tuesday, Oxford Biomedica jumped 18.2 per cent to 22.75p on news that the biotechnology company is in merger discussions with an unnamed company....
International Edition